Potential Investors often look for key drivers that can move a stock in a positive direction. One of those is sales growth. Acerus Pharmaceuticals Corporation (TSX:ASP) of the Other sector, witnessed sales growth of -0.53273 year over year. The firm has a traded value of 38 and has its headquarters in Canada.
Acerus Pharmaceuticals Corporation (TSX:ASP) closed the recent session at 0.250000 with a market value of $40061.
Investors may be combing through all the latest company earnings reports. They may be trying to figure out which companies look like they are going to be strong over the next few quarters. Earnings reports have the ability to cause dramatic stock price swings. Many investors will stay away from making any big trades around earnings announcements. When the dust settles, it may be much easier to determine whether a stock is worth buying or if it should be sold. Keeping a close eye on historical earnings results can provide some good insight. Companies that consistently produce solid earnings may be worth looking into further, especially if the investor is on the fence about getting into the name.
Turning to some key growth data as decimals. One year cash flow growth ratio is calculated on a trailing 12 months basis and is a one year percentage growth of a firm’s cash flow from operations. This number stands at -1.48030 for Acerus Pharmaceuticals Corporation (TSX:ASP). The one year Growth EBIT ratio stands at -4.16568 and is a calculation of one year growth in earnings before interest and taxes. The one year EBITDA growth number holds at -2.40092 which is calculated similarly to EBIT Growth with just the addition of amortization.
Taking even a further look we note that the 1 year Free Cash Flow (FCF) Growth is at -1.46411. The one year growth in Net Profit after Tax is -4.77464 and lastly sales growth was -0.53273.
Acerus Pharmaceuticals Corporation (TSX:ASP) has a current suggested portfolio ownership target rate of 0.01230 (as a decimal) ownership. Target weight is the volatility adjusted recommended position size for a stock in your portfolio. The maximum target weight is 7% for any given stock. The indicator is based off of the 100 day volatility reading and calculates a target weight accordingly. The more recent volatility of a stock, the lower the target weight will be. The 3-month volatility stands at 66.241800 (decimal), the 6-month at 74.756200 and the 12-month at 91.544900. This is the normal returns and standard deviation of the stock price over three months annualized.
Taking look at some key returns and margins data we can note the following: Acerus Pharmaceuticals Corporation (TSX:ASP) has Return on Invested Capital (ROIC) of -6.216198, with a 5-year average of -1.928739 and an ROIC quality score of -0.380073. Why is ROIC important? It’s one of the most fundamental metrics in determining the value of a given stock. It helps potential investors determine if the firm is using it’s invested capital to return profits.
Changing lanes and looking at some Debt ratios, Acerus Pharmaceuticals Corporation (TSX:ASP) has a debt to equity ratio of 0.48068 and a Free Cash Flow to Debt ratio of -0.565781. This ratio provides insight as to how high the firm’s total debt is compared to its free cash flow generated. In terms of Net Debt to EBIT, that ratio stands at -0.22138. This ratio reveals how easily a company is able to pay interest and capital on its net outstanding debt. The lower the ratio the better as that indicates that the company is able to meet its interest and capital payments. Lastly we’ll take note of the Net Debt to Market Value ratio. Acerus Pharmaceuticals Corporation’s ND to MV current stands at 0.050048. This ratio is calculated as follows: Net debt (Total debt minus Cash ) / Market value of the company.
Often times, investors may become worried when the stock market is highly volatile. Being prepared for volatile situations can help ease the fears that come along with turbulence. Following a well-crafted plan might help ride out the ups and downs that are a normal part of dealing with the market. Investors should be prepared for market situations that provide ample opportunities. Although market downturns can be unsettling and cause panic, investors who are able to stay the course and keep calm may be able to spot good buying opportunities when the wider market is selling.
